SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PRXL - Parexel International
PRXL 88.080.0%Oct 9 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Partmann who wrote (34)3/3/1999 10:22:00 AM
From: Jeffrey D  Read Replies (2) of 62
 
PRXL added to H&Q focus list. Here is the story. Jeff

<<

Parexel Intl Corp (PRXL) BUY $22.50 FY99 E:0.93 FY00 E:1.22
Ken Miller kmiller@hamquist.com
Adding PRXL to Focus List; Reiterate BUY
We are adding PAREXEL to our Focus List. We believe investors have an
overly-pessimistic outlook on the March quarter. Investors will particularly
scrutinize four metrics in the upcoming earnings report: earnings growth, new
business signings, margin trends and growth in accounts receivable. We expect
positive news in each. The stock should experience substantial multiple
expansion as growth accelerates in the latter half of CY1999.>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext